Podcasts about Infection

If you've been diagnosed with Hashimoto's but still don't feel like yourself, your gut may be part of the puzzle. In this episode, Brooke sits down with her new team member, Emily, to discuss GI-MAP stool testing, how it works, and what it can reveal about hidden infections, microbial imbalances, and digestive dysfunction that may be impacting thyroid health. You'll learn how comprehensive stool testing can uncover root causes that traditional testing often misses, why personalized protocols are more effective than generic supplement recommendations, and who may benefit most from this type of advanced testing. If you're looking for a deeper understanding of the gut-thyroid connection, this episode is a great place to start. Click HERE o access the show notes for this episode and learn more about how you can work with us 

In this episode of the Medical Matters Podcast, Dr. Peter Brier and Nurse Practitioner Kelly McCormick discuss the recent rise in cases of Ebola and Hantavirus -- the differences, symptoms, and treatments are considered.The goal of this podcast is to provide background, historical context, and explain how the viruses are taking hold. Ebola is largely active in Central and West Africa, and cases may be tracked at this website -- as for Hantavirus, cases are seen in South Africa and South America, and may also be tracked.Further, experts note that the US is likely not fully prepared to guard against an outbreak of either disease.

It's hospital day five. The patient looked better yesterday… but now she's hypotensive, on vasopressors, acidotic, and spiraling toward multi-organ failure. The CT scan doesn't show perforation or megacolon, but your gut tells you this is going south. Do you keep pushing medical therapy… or is it time to operate?Join Drs. Rushabh Dev, Jeffrey Coughenour, Kevin Bartow, Raymond Okeke, and Desra Fletcher from the Emergency General Surgery team in Tiger Country at Mizzou as they tackle one of the deadliest and most challenging diseases acute care surgeons face: fulminant Clostridioides difficile infection. In this Clinical Challenges episode, the panel discusses diagnostic stewardship, ASCRS recommendations, timing of operative intervention and technique, subtotal colectomy versus diverting loop ileostomy with lavage, and physiology that should push surgeons toward definitive source control. Through a real-world high-risk case vignette, the team explores the hardest question in emergency general surgery: when to stop hoping medical therapy will work and pull the operative trigger.Hosts Dr. Rushabh Dev FACS (Moderator, Surgical Attending) – Assistant Professor of Surgery, Associate PD ACS & SCCM Fellowship, SICU Medical Director, Lieutenant Commander United States Navy Reserve  Dr. Jeffery Coughenour FACS (Surgical Attending) – Professor of Surgery and Emergency Medicine, Trauma Medical Director at the University of Missouri SOM Dr. Kevin Bartow FACS (Surgical Attending) –Professor of Surgery, Minimally Invasive Surgeon and General Surgery. Department of General Surgery at the University of Missouri SOM Raymond Okeke – Acute Care Surgery/Surgical Critical Care Fellow, University of Missouri School of Medicine  Desra Fletcher – PGY 3 General Surgery Resident, University of Missouri School of Medicine  Learning ObjectivesBy the end of this episode, listeners should be able to: Define the spectrum of Clostridioides difficile infection (CDI), including non-severe, severe, and fulminant disease, and recognize the physiologic implications of fulminant colitis.  Review contemporary diagnostic stewardship for CDI, including appropriate stool testing, pitfalls of PCR/NAAT interpretation, and the role and limitations of CT imaging in fulminant disease.  Describe evidence-based medical management of fulminant CDI, including high-dose enteral vancomycin, intravenous metronidazole, rectal vancomycin for ileus, and principles of antimicrobial stewardship.  Recognize the high-risk clinical features that should prompt urgent surgical evaluation, including worsening shock, vasopressor dependence, lactate elevation, organ failure, and evolving abdominal exam findings.  Discuss the operative indications and timing for surgery in fulminant CDI and understand why delayed intervention contributes to mortality.  Compare subtotal colectomy with end ileostomy versus diverting loop ileostomy with antegrade lavage, including current evidence, patient selection, limitations of the literature, and ASCRS recommendations.  Review practical operative strategies for subtotal colectomy in unstable patients, including damage-control principles and common technical pitfalls.  Apply clinical reasoning to a complex, high-risk case of fulminant CDI in a patient with decompensated cirrhosis, septic shock, and multi-organ dysfunction.  References ASCRS Clinical Practice Guidelines for *Clostridioides difficile* Infection (2021)  Surgical Management of *Clostridium difficile* Colitis — Neal et al., 2011 (Loop Ileostomy + Lavage Protocol)  Clinical Practice Guidelines for *Clostridioides difficile* Infection in Adults and Children (IDSA/SHEA, 2021 Update)  Adjunctive Hyperbaric Oxygen and Surgical Outcomes in Necrotizing Soft Tissue Infections (Background discussion of severe infection physiology)  Total Abdominal Colectomy Versus Diverting Loop Ileostomy for Fulminant CDI — Systematic Review & Meta-analysis  Current Status of Surgical Therapy for Fulminant *Clostridioides difficile* Colitis  Behind the Knife Episode 648 – Emergency General Surgery Journal Review: *Clostridioides difficile* Infection  Bottom line: Fulminant C. diff is one of the few EGS diseases where the hardest decision is not what operation to perform — it's recognizing when medical therapy has failed before the patient becomes unsalvageable.Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

In this episode, Drs. Jason Silverman and Amber Hildreth talk to Dr. Valeria Cohran about the advances in intestinal rehabilitation care for infants and children with short bowel syndrome including changes nutrition management, line care and use of GLP-2 analogues that have led to decreases in intestinal failure associated liver disease and transplantation. Learning objectivesTo understand the composition and impact of multidisciplinary intestinal rehabilitation teams.To review the historical presentation of intestinal failure-associated liver disease (IFALD) and changes in practice that have reduced its prevalence and severity.To review GLP-2 analogues and their impact on outcomes and quality of life for children with short bowel syndrome. LinksPapers mentioned:PIFCON data paper on IFALDCholestasis and infection in long-term PNManagement of CVL in SBS Position PaperIntestinal Rehabilitation Teams Practice GuidelinePrevious episodes mentioned:Sue Protheroe - Enteral Nutrition in Intestinal FailureDanielle Wendel - Central Line Management in Intestinal Failure (Special JPGN Episode)Ruben Quiros-Tejeira - Multivisceral TransplantationPaul Wales - Surgical Management in Short Bowel SyndromeValeria Cohran & Conrad Cole - Racism in MedicineSend us Fan MailSupport the showThis episode may be eligible for CME credit!  Once you have listened to the episode, click this link to claim your credit.  Credit is available to NASPGHAN members (if you are not a member, you should probably sign up).  And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

This Skeptical Sunday, Jessica Wynn explains how dialysis became a $50B industry where under 40% of patients survive five painful years of dependence.Welcome to Skeptical Sunday, a special edition of The Jordan Harbinger Show where Jordan and a guest break down a topic that you may have never thought about, open things up, and debunk common misconceptions. This time around, we're joined by writer and researcher Jessica Wynn!Full show notes and resources can be found here: jordanharbinger.com/1336On This Week's Skeptical Sunday:Dialysis is a life-sustaining external filtration system for the roughly 800,000 Americans in kidney failure — but it's grueling. Most patients endure three to five hours per session, three times a week, indefinitely, and fewer than 40% survive beyond five years.The financial structure is staggering. Dialysis is a $50 billion-a-year US industry, with Medicare spending about $36 billion annually — roughly 7% of its entire budget for under 1% of the population. Two companies, DaVita and Fresenius, control about 70% of all clinics.The system rewards permanence over cure. Since 1972, Medicare has covered kidney failure for everyone regardless of age, creating guaranteed, indefinite revenue. Transplants and home dialysis are cheaper and better for patients, yet under-incentivized because they cost providers customers.The human and safety toll is severe. Infections cause 36% of dialysis deaths, sepsis mortality runs 100 to 300 times higher than average, and understaffing worsens outcomes. Many patients lose their jobs, mobility, and social lives — some choose to stop treatment entirely.The hopeful part: much kidney disease is preventable or delayable, and you have real power here. Manage diabetes and hypertension aggressively, get your kidneys checked with a simple blood and urine test, and see a nephrologist early — catching it sooner can dramatically slow progression.Connect with Jordan on Twitter, Instagram, and YouTube. If you have something you'd like us to tackle here on Skeptical Sunday, drop Jordan a line at jordan@jordanharbinger.com and let him know!Connect with Jessica Wynn at Instagram (and Instagram!), and subscribe to her newsletters: Between the Lines and Where the Shadows Linger!And if you're still game to support us, please leave a review here — even one sentence helps! Sign up for Six-Minute Networking — our free networking and relationship development mini course — at jordanharbinger.com/course!Subscribe to our once-a-week Wee Bit Wiser newsletter today and start filling your Wednesdays with wisdom!Do you even Reddit, bro? Join us at r/JordanHarbinger!This Episode Is Brought To You By Our Fine Sponsors: Lufthansa Allegris: Go to Lufthansa.com and search for "Allegris" to learn moreCookUnity: 50% off first week: cookunity.com/jordan or code JORDANRevolve Man: 15% off: revolve.com/jordan, code JordanMarathon Rewards: Sign up today: marathonrewards.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, the Bo-Hosts celebrate the 38th Anniversary of Van Halen's multi-platinum sophomore album, OU812.   Released on May 24, 1988, OU812 (pronounced "Oh You Ate One Too") debuted at #1 on the US Billboard 200 chart and was the Sammy Hagar-fronted band's second consecutive studio album to hit the top spot.  The classic, but equally controversial album (due to it's lack of low-end Michael Anthony), spawned four Top-40 singles, including the smash hit "When It's Love". But after 38 years, the Bo-hosts revisit the album's overlooked cookers, such as "AFU", "Source of Infection" and "Black and Blue", to discuss why they should be re-appraised, their VH rankings and their sonic-siblings!So crack open a Sammy libation of choice, set the DeLorean's controls for the sun-drenched days of 1988 and join the Bo-Hosts for an episode so big it needed to be split in half! "What is understood...NEED be discussed"Facebook:https://www.facebook.com/profile.php?id=100085582159917Instagram: https://www.instagram.com/thebogusotisshow/?hl=enX:https://x.com/BogusOtisShowYouTube:https://www.youtube.com/@TheBogusOtisShowTik Tok:https://www.tiktok.com/@thebogusotisshowConnect with the Bo-Hosts:bogusotisshow@gmail.com

Listener discretion is advised! References: Buttner & Arlanger. (May 3, 2022). ST depression does not localise. Available: https://litfl.com/st-depression-does-not-localise/ Cannon, J. W., Khan, M. A., Raja, A. S., et al. (2017). Damage control resuscitation in patients with severe traumatic hemorrhage. Journal of Trauma and Acute Care Surgery, 82, 605-617. Kabra, R., Acharya, S., Kamat, S., & Kumar, S. (2022). ST-Segment Elevation in Lead aVR With Global ST-Segment Depression: Never Neglect Left Main Coronary Artery (LMCA) Occlusion. Cureus. Lee, G.-K., Hsieh, Y.-P., Hsu, S.-W., Lan, S.-J., & Soni, K. (2019). Value of ST‐segment change in lead aVR in diagnosing left main disease in Non‐ST‐elevation acute coronary syndrome—A meta‐analysis. Annals of Noninvasive Electrocardiology, 24. Morrison, C. A., Carrick, M. M., Norman, M. A., et al. (2011). Hypotensive Resuscitation Strategy Reduces Transfusion Requirements and Severe Postoperative Coagulopathy in Trauma Patients With Hemorrhagic Shock: Preliminary Results of a Randomized Controlled Trial. Journal of Trauma: Injury, Infection & Critical Care, 70, 652-663. Rossaint, R., Afshari, A., Bouillon, B., et al. (2023). The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Critical Care, 27. Tamura, A. (2014). Significance of lead aVR in acute coronary syndrome. World Journal of Cardiology, 6(7), 630. Uthamalingam, S., Zheng, H., Leavitt, M., Pomerantsev, E., Ahmado, I., Gurm, G. S., & Gewirtz, H. (2011). Exercise-Induced ST-Segment Elevation in ECG Lead aVR Is a Useful Indicator of Significant Left Main or Ostial LAD Coronary Artery Stenosis. JACC: Cardiovascular Imaging, 4, 176–186. Weymouth, W., Long, B., Koyfman, A., & Winckler, C. (2019). Whole Blood in Trauma: A Review for Emergency Clinicians. The Journal of Emergency Medicine, 56, 491-498. Wang, A., Singh, V., Duan, Y., Su, X., Su, H., Zhang, M., & Cao, Y. (2020). Prognostic implications of ST‐segment elevation in lead aVR in patients with acute coronary syndrome: A meta‐analysis. Annals of Noninvasive Electrocardiology, 26.

Welcome to the latest Midlife Minute. I've been getting many questions about viruses, bacterial vaginosis, and recurrent infections. So, today, I'm stepping a little outside our usual topics to explore how changes in the gut microbiome can directly influence the vaginal microbiome. Join me as I clarify what actually happens in the body during perimenopause and menopause, and explain why those shifts matter more than most women realize. IN THIS EPISODE, YOU WILL LEARN: Three changes that occur simultaneously during perimenopause and menopause, and how those changes increase our susceptibility to viruses like herpes. Why declining estrogen weakens the vaginal microbiome How gut microbiome changes in midlife affect the ability to recycle estrogen via the estrobolome Why the gut barrier becomes less stable and more permeable during perimenopause and menopause, and how that can trigger immune responses and low-grade inflammation How hormonal fluctuations can trigger viral outbreaks and increase the likelihood of shingles What research shows about hormone replacement therapy and lower rates and recurrence of severe herpes simplex infections Why bacterial vaginosis is becoming more common in midlife How to balance and support the gut and vaginal microbiome in midlife Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website. Submit your questions to support@cynthiathurlow.com Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow.  Cynthia's Menopause Gut Book is on presale now! Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line Links: 1. Menopausal shift on women's health and microbial niches 2. The Effect of Menopause on the Innate Anti-Viral Activity of Cervicovaginal Lavage https://pmc.ncbi.nlm.nih.gov/articles/PMC4519412/  3. Spotlight on the Gut Microbiome in Menopause: Current Insights 4. Shingles and Menopause: Is There a Connection? 5. The Impact of Hormonal Replacement Therapy on Herpes Simplex Infection and Gingival Health in Post-Menopausal Women  6. The Menopause Transition, Vaginal Health, and Your Vaginal Microbiome 7. Probiotics in the Prevention and Treatment of Postmenopausal Vaginal Infections: Review Article 8. G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo 9. Association between Acquisition of Herpes Simplex Virus Type 2 in Women and Bacterial Vaginosis  10. Recalcitrance of bacterial vaginosis among HSV-2 seropositive women   

Send us Fan MailOn the latest episode of Going Under: Anesthesia Answered, we walk through the reported details around Kyle Busch's surprising death and translate the headlines into a clear medical timeline from sinus symptoms to pneumonia, bacteremia, and sepsis. We also explain why “coughing blood” can be a sign of severe lung injury like ARDS, and what early treatment might have changed. Have a question for Dr. Brian Schmutzler? Submit them to any of the social media pages below or on his website at https://www.drbrianschmutzler.com/Facebook: https://www.facebook.com/drbrianschmutzlerInstagram: https://www.instagram.com/drbrianschmutzlerTikTok: https://www.tiktok.com/@drbrianschmutzler?lang=enProvider or Medical Student?? Subscribe to his Patreon Page to get exclusive content and access to Medical Blocks:https://www.patreon.com/user?u=89356957&utm_medium=clipboard_copy&utm_source=copyLink&utm_campaign=creatorshare_creator&utm_content=join_linkThanks to our show sponsor: Butterfly Networkhttps://store.butterflynetwork.com/us/en/?rsCode=BRIAN25Get $750 off the latest iQ3 at ButterflyNetwork.comSupport the show

Drug-resistant infections are a major public health threat around the world. To fight them, scientists are constantly trying to find and develop new antibiotics. Now, researchers say artificial intelligence is helping speed their search. Miles O'Brien reports. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

In this episode of Resiliency Radio with Dr. Jill, Dr. Jill Carnahan speaks with Dr. Melissa Jones about the growing epidemic of PANS, PANDAS, neuroinflammation, and autoimmune brain disorders in children and adults. Dr. Jones shares how her journey from conventional pediatric neurology into functional medicine transformed the way she approaches complex neuropsychiatric conditions. Together, they explore the root causes behind sudden-onset OCD, anxiety, tics, behavioral changes, and neurological symptoms linked to infections, immune dysfunction, mold toxicity, and gut inflammation. This episode provides hope for families navigating these often misunderstood conditions and offers practical insight into how a root-cause, functional medicine approach can support recovery and healing.

Your fatigue, brain fog, and lingering symptoms after COVID may not be random. The spike protein can keep disrupting your body long after the initial infection clears. Evan H. Hirsch, MD, breaks down 13 distinct mechanisms through which the spike protein continues affecting energy production, immune function, circulation, the gut, and nervous system regulation in people dealing with Long COVID, ME/CFS, and chronic fatigue. This episode also explains why so many people address symptoms one at a time and still plateau, and what the layer underneath the 13 mechanisms actually is. In this episode, you'll learn: Why the spike protein does not always leave when the infection clears How microclots block oxygen delivery even when labs look completely normal The biological explanation for post-exertional malaise and why pushing harder makes it worse Why 57% of Long COVID clients develop exercise-induced dysautonomia How gut disruption and serotonin depletion drive fatigue, brain fog, and mood changes What the Toxic 5 are and why they keep the 13 mechanisms running long after the acute illness is gone Discover your fatigue score and the root causes keeping you stuck: https://myfatiguescore.com Free Fatigue Masterclass: https://fixyourfatigue.com See real results: https://energymdmethod.com/results Chapters: 00:00 - Introduction 01:49 - The 13 Spike Protein Mechanisms Explained 07:52 - Why Treating Symptoms One at a Time Leads to a Plateau 09:34 - The Toxic 5 and the Three-Layer Recovery Model 11:13 - How Heavy Metals and Chemicals Keep the Fire Going 12:01 - Why Mold Is One of the Most Missed Perpetuators 12:28 - Infections, Nervous System Dysfunction, and What the Tests Miss 13:39 - The Bottom Line and What to Do Next 15:52 - Free Masterclass and Next Steps Subscribe to the EnergyMD Podcast for weekly conversations with leading experts on resolving ME/CFS and Long COVID by addressing the real root causes. . For more information about Evan and his program, Click Here.  Prefer to watch on Youtube? Click Here.  Please note that any information in this episode is for educational purposes only and does not constitute medical advice.

In this episode of New Frontiers in Functional Medicine, Richard Horowitz joins Kara Fitzgerald to explore the connection between persistent infections, inflammation, and chronic disease. The discussion highlights emerging research linking Borrelia burgdorferi (Lyme disease) to amyloid production and Alzheimer's biomarkers, along with the clinical implications of Dr. Horowitz's MSIDS model. Topics include biofilm persistence, co-infections, treatment resistance, and multi-targeted strategies for addressing complex, chronic conditions such as Lyme disease, ME/CFS, fibromyalgia, and long COVID. This episode offers clinicians a more integrated framework for evaluating and managing treatment-resistant patients. Full show notes + references: https://www.drkarafitzgerald.com/fxmed-podcast/ GUEST DETAILS Richard Horowitz is a board-certified internist and founder of the Hudson Valley Healing Arts Center. For more than 40 years, he has treated over 13,000 patients with Lyme disease and complex chronic illness using both conventional and integrative approaches. Dr. Horowitz is the developer of dapsone combination therapy and author of the New York Times bestsellers Why Can't I Get Better? and How Can I Get Better? His newest book, Ending Chronic Illness, explores how his MSIDS model may apply to many chronic diseases beyond Lyme, offering a broader systems-based framework for diagnosis and treatment. https://cangetbetter.com/ THANKS TO OUR DIAMOND SPONSORS Time—Line Nutrition: http://pro.timeline.com/ DUTCH: https://dutchtest.com/for-providers Biotics Research: https://www.bioticsresearch.com/ THANKS TO OUR GOLD SPONSORS Equelle: http://equelle.com Fullscript Journeys: http://www.fullscript.com/journeys-kara CONNECT with DrKF Want more? Join our newsletter here: https://www.drkarafitzgerald.com/newsletter/ Or take our pop quiz and test your BioAge! https://www.drkarafitzgerald.com/bioagequiz YouTube: https://tinyurl.com/hjpc8daz Instagram: https://www.instagram.com/drkarafitzgerald/ Facebook: https://www.facebook.com/DrKaraFitzgerald/ DrKF Clinic: Patient consults with DrKF physicians including Younger You Concierge: https://tinyurl.com/yx4fjhkb Younger You Practitioner Training Program: https://www.drkarafitzgerald.com/trainingyyi/ Younger You book: https://tinyurl.com/mr4d9tym Better Broths and Healing Tonics book: https://tinyurl.com/3644mrfw

Download Welcome to LOTC episode 482. This week the crew is joined by Victoria Chambers to countdown our top 5 horror movies from the year 2004. We hope you will enjoy everyone's list. We want to thank all the callers who called in with their list's as well. This was and is always fun recording these type shows. We want to Thank Victoria for being on the episode this week. We are putting everyone's top 5's below but we hope you will listen as well.TOP 5 LIST'SVICTORIA: 1. PREMONITION2. R-POINT3. INCIDENT AT LOCH NESS4. DEAD & BREAKFAST5. DARK TALES OF JAPANDAVE1. DAWN OF THE DEAD2. SHAUN OF THE DEAD3. THREE... EXTREMES4. CREEP5. INCIDENT AT LOCH NESSBILL1. SAW2. DAWN OF THE DEAD3. SHAUN OF THE DEAD4. INFECTION5. CUBE ZEROPEARL1. SAW2. CREEP3. THREE... EXTREMES / DARK TALES OF JAPAN4. THE EXORCIST THE BEGINNING5. VAN HELSING / PHANTOM OF THE OPERAGREGH1. SHAUN OF THE DEAD2. DAWN OF THE DEAD3. DEAD & BREAKFAST4. THREE... EXTREMES5. SATAN'S LITTLE HELPERLOTC Links :Land Of The Creeps InstagramGregaMortisFacebookTwitterLand Of The Creeps Group PageLand Of The Creeps Fan PageJay Of  The Dead's New Horror Movie PodcastYoutubeInstagramEmailLetterboxdDr. ShockDVD Infatuation TwitterDVD Infatuation WebsiteFacebookHorror Movie PodcastJay Of The Dead's New Horror Movies PodcastYouTube ChannelLetterboxdDVD Infatuation PodcastThe Illustrated Fan PodcastBill Van Veghel LinkFacebookLetterboxdMusic,Movies,Sports & Stuff PodcastFacebook Music Movies Sports & StuffTwisted Temptress LinkLetterboxdLOTC Hotline Number1-804-569-56821-804-569-LOTCLOTC Intro is provided by Andy Ussery, Below are links to his social mediaEmail:FacebookTwitterOutro music provided by Greg Whitaker Below is Greg's Twitter accountTwitterFacebook

Dr. Margarita Fedorova discusses whether a vaccine ingredient is quietly protecting the brain.  Show citation:  Taquet M, Todd JA, Harrison PJ. Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections. NPJ Vaccines. 2025;10(1):130. Published 2025 Jun 25. doi:10.1038/s41541-025-01172-3 Show transcript:  Dr. Margarita Fedorova:  Welcome to Neurology Minute. My name is Margarita Fedorova, and I'm a neurology resident at the Cleveland Clinic. Today we're exploring a study that raises a compelling question. Could a vaccine ingredient be quietly protecting the brain? A recent study by Taquet et al., published in npj Vaccines in 2025, investigated whether vaccination with an AS01-adjuvanted vaccine is associated with a lower risk of dementia. You might know it as the immune-boosting ingredient in Shingrix, the shingles vaccine, and Arexvy, the new RSV vaccine. We already know from prior work that the Shingrix vaccine was associated with a reduced risk of dementia, but the question this paper asks is why. Is it because preventing shingles itself protects the brain, or is there something specific about the adjuvant that's doing the work? To answer this, the researchers used a large US electronic health record database comparing over 35,000 people who received the AS01-adjuvanted RSV vaccine, over 100,000 who received the AS01-adjuvanted shingles vaccine and over 78,000 who received both. Each matched against individuals who got the seasonal flu vaccine instead. The findings were interesting. People who received the RSV vaccine had a 29% lower risk of new dementia diagnosis over the following 18 months. Those who received the shingles vaccine had an 18% increase in time without dementia, and those who received both had a 37% increase in dementia-free time. Here's a key insight. Both vaccines target completely different viruses, but both contain the same adjuvant. The fact that a similar protective signal was seen with both suggests the benefit may not be about which virus is prevented, and it may be about the AS01 itself. Why might an adjuvant protect the brain? AS01 contains two active components, monophosphoryl lipid A, known as MPL, and QS21. Together they activate macrophages and dendritic cells, triggering cascade that includes a production of interferon gamma. In animal models, stimulation of a receptor called toll-like receptor 4, which MPL activates, has been shown to reduce Alzheimer's-like pathology. The authors also point out that the protective effect appears within just a few months of vaccination, which is hard to explain purely by prevented infections and may point instead to a direct immunological mechanism. Very important caveat. This is an observational study, not a randomized trial, so we can't prove causation. There was also uncertainty about which brand of RSV vaccines some patients received, which could affect the strength of the AS01-specific conclusion. And with all of the dementia studies, it's unclear whether the vaccines prevent dementia or delay its onset. Though even a delay would be clinically meaningful given how few tools we have. What does this mean for clinical practice? For now, it doesn't change your vaccination recommendations. Both Shingrix and Arexvy already indicated in appropriate patients for the primary purposes, but it adds an intriguing possible benefit when counseling patients who ask about vaccines. And it opens the door to a genuinely exciting question. If AS01 has neuroprotective properties, could it be studied in a therapeutic target in its own right? That's the Neurology Minute for today. Keep exploring and we'll see you next time. If you want to read more, please find the paper by Maxime Taquet, et al., titled Lower Risk of Dementia with AS01-Adjuvanted Vaccination Against Shingles and Respiratory Syncytial Virus Infections, published in npj Vaccines in June 2025. 

What happens when a sharp-eyed cruise ship doctor spots a hantavirus amid a sea of hangovers and flu symptoms? In this high-stakes episode of the Prolonged Field Care Podcast, Dennis sits down with Dr. Ryan Maves — combat-experienced infectious disease expert and military medicine veteran — to break down the shocking recent Andes virus outbreak.Far from the next global pandemic, hantaviruses are a real, rodent-borne threat that has hit soldiers before (Korean War, anyone?) and can strike deployed units in austere environments. Ryan delivers hard-hitting insights on rapid diagnosis, the “off-script” decompensation that screams hantavirus, supportive care when there's no magic antiviral, and — most importantly — prevention strategies that actually work in the field.If you operate in rodent-infested buildings, set up in abandoned structures, or just want to trust your gut when a patient goes south fast, this episode is required listening. Real talk from the A-team who are currently managing these patients stateside.Key TakeawaysClassic presentation: Flu-like prodrome (fever, fatigue, myalgias, GI upset) for a few days followed by sudden shock, respiratory failure, and decompensation.Bedside diagnostic gold: Thrombocytopenia (low platelets) + hemoconcentration (elevated hematocrit) in a previously healthy patient = major red flag.Treatment reality: Purely supportive — fluids, pressors, oxygen, renal support. No silver-bullet antiviral; ribavirin has limited data at best.Prevention beats everything: Humans are dead-end hosts. Avoid aerosolizing rodent urine/feces/droppings (no dry sweeping!). Use bleach, N95 (or equivalent), gloves, and gown.Human-to-human spread: Extremely rare except with Andes virus (this outbreak strain). Still, treat unknowns with respect.Military relevance: Endemic in deployment zones worldwide; occupying previously rat-infested buildings is a classic risk. History tied directly to U.S. troops in Korea.Mindset: When things go “off script,” trust your clinical instincts over machines. The best tool in the field is still an experienced medic's gut.Chapters00:00 – Welcome back to the PFC Podcast00:26 – Introducing Dr. Ryan Maves & the cruise ship outbreak00:55 – Why this isn't the next pandemic… but still matters03:04 – Military relevance: hantaviruses in deployment zones03:51 – How the cruise ship doc nailed the diagnosis05:27 – Clinical syndrome & the “virus-y” prodrome07:04 – Key labs: thrombocytopenia + hemoconcentration explained09:42 – Disease progression and why young healthy people can still crash10:50 – History of hantaviruses (Korean War → Sin Nombre → Andes)12:21 – Who actually dies and why14:50 – Biocontainment units and the military experts on the case17:35 – Treatment in the field: supportive care only19:35 – Shock management: distributive + capillary leak20:55 – Prevention is king: rodent control & PPE tactics24:22 – Human-to-human transmission (Andes virus exception)27:31 – Infection control, differential diagnosis, and real-world precautions30:08 – Final thoughts: clinical acumen, zoonoses, and trusting your instincts32:32 – Closing & where to find more PFC contentGrab your N95 and hit playFor more content, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.prolongedfieldcare.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Consider supporting us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/ProlongedFieldCareCollective⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.lobocoffeeco.com/product-page/prolonged-field-care⁠

Full Show Summary: The Tara Show (Memorial Day — May 25, 2026)Host: Ryan Wrecker (filling in for Tara)Hour 1: War, Peace, and Political HistorySegment 1: Wrecker analyzed the fragile 60-day U.S.–Iran ceasefire framework negotiated over the weekend [2026 Iran war ceasefire]. He contrasted Trump's unpredictable, heavy-handed tactics with the methodical approach a Biden-Harris administration would have taken.Segment 2: The host offered opening Memorial Day salutations before diving into Senator Marco Rubio's staunch defense of the administration's foreign policy, highlighting Rubio's warning to Republicans: "Don't question Trump" on the Iran deal.Segment 3 & 4: Political historian Rich Rubino joined the broadcast to break down the broader political landscape, concluding with a lively debate over the historical trivia of who truly deserves the title of the first American President.Hour 2: Local Chaos, Cultural Shifts, and Consumer ScamsSegment 5: Wrecker pivoted to breaking news, reporting on a chaotic stampede at a major biker event in Horry County and a developing situation involving an active gunman in Washington, D.C.Segment 6: The tone shifted to cultural nostalgia as Wrecker embraced his identity as a "geriatric millennial," reminiscing about the freedom, landlines, and unique social dynamics of growing up in a pre-internet world.Segment 7 & 8: Consumer advocate Kerry Lutz joined the show for a piercing exposé on "America's Great Parking Scam," detailing the predatory tactics, hidden fees, and corporate greed behind modern municipal and private parking systems.Hour 3: Cowboy Logic, Military Reality, and Public HealthSegment 9: Author Patrick Dorinson discussed his book, The Common Sense Cowboy's Guide to Life [Common Sense Cowboys Guide Life], urging Americans to ditch partisan anxiety and value real-world wisdom over institutional degrees.Segment 10: Wrecker reacted to Pete Hegseth's blunt address to military cadets, dissecting his viral warning that their sole purpose is lethal combat leadership, not serving as a testing ground for social experiments.Segment 11 & 12: Infection prevention specialist Rayne Guest, CEO of ArrowClean [ArrowClean], closed the hour by warning listeners about modern germ warfare, shifting sanitation failures, and the rising threat of recent viral outbreaks.Hour 4: The True Meaning of Memorial Day and CompromiseSegment 13: Wrecker delivered a somber monologue re-centering the audience on the true meaning of Memorial Day, honoring Gold Star families and the military members who made the ultimate sacrifice.Segment 14: The broadcast tied the holiday back to current events, examining the "Book of Compromise" required to end conflicts and questioning the fierce pushback Trump is receiving from hard-line Republicans over the Iran deal.Segment 15: Author Aaron Perlut joined the show to discuss his book, The Death of Compromise [Death Compromise Aaron Perlut], detailing how hyper-partisanship has systematically destroyed America's ability to find common ground.Segment 16: The four-hour broadcast concluded on a deeply patriotic note with a full playback of Ray Charles' iconic, soulful rendition of "America the Beautiful" as a final tribute to the nation's fallen heroes.

Astrology: Can This Ancient Practice Impact Your Life? Astrology is an ancient practice that's been in and out of popularity for centuries. Believers use this pseudoscience as a way to find structure and purpose in the chaos of life. Our experts explain how astrology has lasted the test of time and how it could advise your life in different areas, such as love and success. Guests: Neda Farr, celebrity astrologer, creator, Starcrossed App Steven Vanden Broecke, Ph.D., professor of history of science, Ghent University   Q-Tips, Ear Candling, And Everything You Need To Know About Earwax All of that time you spend digging earwax out of your ear isn't just a waste of time, but can be damaging your health. Earwax is a self-cleaning substance that protects our ears from infection and debris. Dr. Andrew Tagg explains the wax's various roles and when to know when you truly need a cleaning. Guest: Dr. Andrew Tagg, pediatric emergency physician, associate professor, University of Melbourne, co-founder, Don't Forget The Bubbles Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

A single sauna session raises your body temperature to a fever-like range, which activates your immune system and moves defensive cells into circulation where they can respond faster to infections Your immune system reacts immediately during heat exposure, with key immune cells increasing right after a session and some staying elevated afterward, giving you a short-term advantage against incoming pathogens The benefit comes from reaching a specific internal temperature, not just sitting in a hot room, which is why tracking your body temperature gives you more precise and effective results Regular sauna use trains your immune system to respond more quickly over time, improving your baseline ability to detect and fight infections before they take hold Heat works best when combined with strong foundational habits like proper nutrition and energy production, ensuring your immune system has both the signal and the fuel to respond efficiently

Q-Tips, Ear Candling, And Everything You Need To Know About Earwax All of that time you spend digging earwax out of your ear isn't just a waste of time, but can be damaging your health. Earwax is a self-cleaning substance that protects our ears from infection and debris. Our expert this week explains the wax's various roles and when to know when you truly need a cleaning. Guest: Dr. Andrew Tagg, pediatric emergency physician, associate professor, University of Melbourne, co-founder, Don't Forget The Bubbles Host: Greg Johnson Producer: Kristen Farrah Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

10 million deaths a year.  That is how many people are predicted to die from antibiotic-resistant infections if we do not find new treatments. In today's episode, Professor Martha Clokie and Professor Tim Spector explore the secret gut viruses, known as phages, being studied to fight deadly infection, target cancer cells, and to protect your gut microbiome.  Martha is a world-leading expert on the mysterious phage and, for the last 20 years, has pioneered research to revolutionise the treatment of infections without antibiotics. She explains why antibiotic resistance is a growing global threat, why everyday infections are becoming harder to treat, and how some bacteria are now resistant to every antibiotic available. We explore how the viruses in our gut may help solve this problem, and how scientists may one day use them to deliver highly targeted cancer treatment. By the end of the episode, you'll have some ideas to help support a healthier gut ecosystem and understand how to increase the number of friendly gut viruses that live inside you. The science is still early, but the message is clear: the small choices we make every day are shaping our long-term resilience to disease. If viruses can help protect us from infection rather than cause it, how much of human health are we only just beginning to understand?

Mark Cuban joins Rav Arora on The Illusion of Consensus for a wide-ranging debate on DEI, wokeness, corporate hiring, race-based diversity goals, merit, quotas, and the backlash against progressive workplace policies. The billionaire entrepreneur, Shark Tank investor, Dallas Mavericks minority owner, and Cost Plus Drugs co-founder argues that businesses should cast a wider net for talent while still hiring the most qualified person, as Rav challenges whether corporate diversity pledges after George Floyd and Black Lives Matter became virtue signalling or a form of discrimination. They discuss EEOC data, Starbucks, Nike, JPMorgan, Pfizer, Microsoft, United Airlines, HBCUs, minority representation, universities, DEI departments, activists such as Ibram X. Kendi and Robin DiAngelo, and the Trump administration's push to dismantle DEI programmes. The conversation also revisits their previous disagreement over Covid mandates, mRNA vaccine side effects, public health ethics, Joe Rogan, pandemic policy, and whether the response to Covid created lasting mistrust in institutions. Cuban and Arora cover how business leaders navigate culture war pressure, shareholder interests, free speech, corporate virtue signalling, political polarisation, independent media, and the future of race, merit, and fairness in American companies. Subscribe to Rav's Substack for exclusive content: https://www.illusionconsensus.com/ 0:00 - Intro 02:29 — The Clash Begins 04:04 — Mark Cuban Defines DEI His Way 05:52 — “That's Not What DEI Means!” 08:29 — Are Racial Quotas Real? 12:47 — Corporate Virtue Signalling Exposed 21:13 — Should Race Ever Matter in Hiring? 29:34 — Diversity vs. Meritocracy 48:04 — Do Companies Really Even Follow DEI? 57:42 — Does DEI Actually Work? 01:21:31 — Race-Based Goals vs Pure Merit-Based Hiring 01:36:45 — Final Thoughts and Common Ground 01:38:39 — Arora challenges Cuban on campus censorship 01:41:24 — Cuban on discrimination from both political sides 01:42:59 — Why Cuban required Mavericks staff vaccinations 01:43:57 — Arora disputes community benefit of mandates 01:52:57 — Cuban's “herd immunity in three months” argument 02:05:02 — FDA internal disagreements over vaccine approval 02:05:31 — White House pressure and military mandates 02:25:00 — Comparing Covid and vaccine-induced myocarditis 02:36:23 — Infection fatality rate and serious adverse events

In this episode of Resiliency Radio with Dr. Jill, Dr. Jill Carnahan welcomes Dr. Richard Horowitz, one of the world's leading experts in chronic illness and tick-borne disease, to discuss the groundbreaking science behind the MSIDS model and its implications for conditions ranging from Lyme disease to Alzheimer's. Dr. Horowitz shares revolutionary findings connecting chronic infections, inflammation, environmental toxins, gut dysfunction, and immune imbalance to persistent disease. He also discusses a surprising breakthrough involving Alzheimer's biomarkers and chronic Lyme treatment using his innovative dapsone protocol. This powerful conversation explores how addressing the root causes of inflammation and chronic illness may transform the future of medicine and offer hope for patients struggling with complex, unresolved health conditions.

Physician-scientist Dr. Robert Drummond talks about the latest on the hantavirus and how the controversial conversation about the credentials of Cheyenne Bryant is a lesson for Black professionals.Become a supporter of this podcast: https://www.spreaker.com/podcast/tavis-smiley--6286410/support.

Plus: WHO officials speak on the Ebola outbreak, takeaways from U.S. primaries, Carney is in B.C., Quebec's Premier returns from France, and who controls your water? Ontario's privatization push. We love feedback at The Big Story, as well as suggestions for future episodes. You can find us: Through email at hello@thebigstorypodcast.ca  Or @thebigstory.bsky.social on Bluesky

What is it? Join the co-hosts for the big reveal as they share personal stories and approaches on how to recognize early warning signs, avoid common bedside blind spots, deliver compassionate care, and act fast with practical, shift-ready strategies that protect patients.   MEET OUR CO-HOSTS Kellye' McRae, MSN-Ed, RN is a dedicated Med-Surg Staff Nurse and Unit Based Educator based in South Georgia, with 12 years of invaluable nursing experience. She is passionate about mentoring new nurses, sharing her clinical wisdom to empower the next generation of nurses. Kellye' excels in bedside teaching, blending hands-on training with compassionate patient care to ensure both nurses and patients thrive. Her commitment to education and excellence makes her a cornerstone of her healthcare team.   Marcela Salcedo, RN, BSN is a Floatpool nightshift nurse in the Chicagoland area, specializing in step-down and medical-surgical care. A member of AMSN and the Hektoen Nurses, she combines her passion for nursing with the healing power of the arts and humanities. As a mother of four, Marcela is reigniting her passion for nursing by embracing the chaos of caregiving, fostering personal growth, and building meaningful connections that inspire her work. Hayley Sweetser, MSN, APRN, AGCNS-BC, MEDSURG-BC, CPHQ, WTA-C is a Clinical Nurse Specialist in Newark, Delaware who provides support to patients and caregivers within the Acute Medicine Service Line at ChristianaCare. She is working towards reducing overall patient harm events within the service line through collaboration with bedside nurses, physicians, and other specialties. Hayley has a strong passion for medical-surgical nursing and has spent her whole nursing career in this specialty. She strives to advance medical-surgical nursing practice by encouraging alignment with evidence-based practice.   Eric Torres, ADN, RN, CMSRN is a California native that has always dreamed of seeing the World, and when that didn't work out, he set his sights on nursing.  Eric is beyond excited to be joining the AMSN podcast and having a chance to share his stories and experiences of being a bedside medical-surgical nurse.   Sydney Wall, RN, BSN, CMSRN has been a med surg nurse for 5 years. After graduating from the University of Rhode Island in 2019, Sydney commissioned into the Navy and began her nursing career working on a cardiac/telemetry unit in Bethesda, Maryland.  Currently she is stationed overseas, providing care for service members and their families.  During her free time, she enjoys martial arts and traveling.  Trish West, DNP, MSN, CMSRN, PCCN, CEN, NEA-BC, FAMSN is a passionate nurse leader whose career reflects both expertise and a heartfelt commitment to advancing patient care. Trish's credentials include being a Certified Medical Surgical Registered Nurse, Progressive and Emergency Nursing, Nursing Executive Advanced, and most recently, induction as a Fellow in the Academy of Medical Surgical Nursing. She enjoys spending time with her husband Mark and their five children. Her favorite motto, "Never underestimate the difference you can make," truly captures the spirit with which Trish approaches both professional and personal endeavors.   

In this episode of The ICHE Podcast, host Dr. Dave Calfee sits down with Kavita Bhavan, MD, Sara Keller, MD, MPH, MSHP, Deborah Lockard, BSN, MPH, and Sara Szathmary, BSN, RN, CNRI to discuss their recent publications in ICHE. The authors discuss what current evidence tells us about CLABSI incidence in outpatient infusion populations, why surveillance data remain limited, and the unique challenges healthcare organizations face when trying to monitor and prevent infections outside the acute care setting. Featured ICHE papers Hannum S, Marsteller J, Gurses AP, … Keller SC. Reducing home infusion CLABSI through a dashboard and toolkit implementation. Infect Control Hosp Epidemiol 2026;47(5): 433-440. Johnson K, Alvarez KS, Jaybanks A, …Bhavan K. Rates of line associated bloodstream infections in self-administered outpatient parenteral antimicrobial therapy compared to standard of care: 11 years of data at a safety net hospital. Infect Control Hosp Epidemiol 2026;47(5): 533-535 Other relevant resources: Keller SC, Hannum SM, Weems K, et al. Implementing and validating a home-infusion central-line-associated bloodstream infection surveillance definition. Infect Control Hosp Epidemiol 2023;44:1748–1759. https://nhicpc.org/

Plus: The World Health Organization is warning about an Ebola outbreak in two African countries, the U.S. has called off military action against Iran, Three Canadian police officers have been arrested in Barcelona, allergy season in Canada is expected to be worse than previous years, and is Canada ready for another wildfire season? We love feedback at The Big Story, as well as suggestions for future episodes. You can find us: Through email at hello@thebigstorypodcast.ca  Or @thebigstory.bsky.social on Bluesky

In episode 77 of Going anti-Viral, Dr Debika Bhattacharya joins host Dr Michael Saag to discuss the management of hepatitis B virus (HBV) infection and vaccination. Dr Bhattacharya is a Clinical Professor at the University of California Los Angeles (UCLA) David Geffen School of Medicine and specializes in the management of HIV and HIV/viral hepatitis coinfection and sees patients with viral hepatitis and HIV/viral hepatitis coinfection at UCLA and its affiliated clinics. Her research involves viral hepatitis clinical therapeutics and long-term clinical outcomes in persons with HIV/viral hepatitis or viral hepatitis alone. Dr Saag and Dr Bhattacharya discuss HBV infection and vaccination, especially among people with HIV addressing prevalence, serology interpretation, vaccination strategies, and management of hepatitis B in the context of HIV treatment. They also reinforce the need for more research into therapies that will lead to a cure for hepatitis B. 0:00 – Introduction 1:16 – Understanding hepatitis B and its impact on people with HIV  2:56 – Vaccination strategies for hepatitis B 4:53 – Interpreting hepatitis B serology results 8:38 – Vaccination protocols and recommendations 13:19 – Managing patients with hepatitis B 14:29 – Long-acting therapies and hepatitis B risks 17:29 – Screening and monitoring for hepatitis B 19:01 – Navigating core antibody positivity 23:36 – The importance of antibody titers 28:23 – Final thoughts on hepatitis B management Resources: Going-anti-Viral: Episode 31 - Will we ever have a cure for hepatitis B? - Dr Kenneth ShermanYouTube:  https://youtu.be/yh48RFOrISk Apple Podcasts:  https://podcasts.apple.com/us/podcast/episode-31-will-we-ever-have-a-cure-for-hepatitis-b/id1713226144?i=1000677466892 __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Chronic inflammation explained—if you're dealing with fatigue, brain fog, or ongoing health issues, this episode uncovers the real root causes and how advanced lab testing can help you finally heal. In this powerful conversation, Dr. Greg Jones sits down with Dr. Clement Lee, a licensed Naturopathic Medical Doctor (NMD), to break down why so many people feel unwell despite “normal” lab results.In this episode, you'll learn how chronic inflammation impacts aging, energy, and cognitive function—and why it's often missed in standard healthcare. Dr. Lee also explains the importance of comprehensive lab testing, including deeper biomarkers and tools like the Metabolic Vulnerability Index (MVX), to assess long-term health risks and optimize recovery.We also explore cutting-edge therapies such as peptide therapy, ozone therapy, and regenerative injections, along with foundational strategies like sleep, hydration, and nutrition that are critical for reducing inflammation and restoring health.If you've been searching for answers to unresolved health issues, this episode provides a clear, science-backed roadmap to understanding chronic inflammation and taking actionable steps toward healing.

Mens Room Question: What infected you?

Mens Room Question: What infected you?

You eat clean, you exercise, and yet you are constantly exhausted, bloated, and struggling with brain fog. Your doctor says your labs are normal, but what if conventional tests are entirely missing the root cause?. Today, we uncover the hidden epidemic of parasitic infections—an issue affecting over 60 million Americans and 1 billion people worldwide. Sponsors: Sunlighten Sauna: https://get.sunlighten.com/axepodcast Manukora Manuka Honey: https://manukora.com/axe Caraway Home: carawayhome.com/drjoshaxe (Use code DRJOSHAXE) for an exclusive discount Watch The Dr. Josh Axe Show every Monday & Thursday on YouTube: ⁠⁠⁠⁠https://www.youtube.com/@drjoshaxe?sub_confirmation=1⁠⁠⁠⁠ 

TWiV explains mRNA delivery of mosaic-8 pan-sarbecovirus RBD vaccines, and how toll-like receptor 7 alters the maternal immune landscape during influenza A infection to increase maternal and fetal morbidity, Hosts: Vincent Racaniello, Rich Condit, and Kathy Spindler Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Support science education at MicrobeTV Positions in Rosenfeld Lab (email) RFK Jr. driving vast inquiry into vaccines (NY Times) Indiana plant biologist locked out of lab by school (Science) Trump cuts CDC role in PEPFAR (Science) Ralph Baric retires (The Assembly) Baric to fight NIH funding ban (Science) Ebola outbreak in DRC (npr) Persistence of Andes virus RNA in human semen (Viruses) mRNA delivery of mosaic-8 pan-sarbecovirus RBD vaccines (Cell Rep) Science will break your heart (TWiV 920) TLR7 and maternal and fetal morbidity during influenza (Sci Adv) Letters read  on TWiV 1323 Timestamps by Jolene Ramsey. Thanks! Weekly Picks Kathy – Bloomberg Connects app and What's in Bloom  Peony Season 2026 Bloom Tracker Rich – Medpage Today: What you need to know about hantavirus Vincent – Apollo 11 Almost Never Left the Moon Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.

A Lasting Legacy: How Brain Donation Is Advancing Autism Research While organ donation can help save a life, brain donation can help save thousands. Specifically for autism, brain donations are helping researchers uncover the biological causes of the disorder to improve the quality of life for future generations. Our experts highlight the critical need for donation awareness and participation. Guests:  Dr. David Amaral, scientific director, Autism BrainNet, Director of Research, UC Davis MIND Institute Kathy Stein, donor's loved one   Fighting The Status Quo: The Rebels Who Changed Public Health Forever Prevention is built into so many aspects of our lives, from coffee cup lids to seatbelts. However, many of these life-saving innovations were historically met with extreme public and professional resistance. Our expert explores "preventioneers" – the people who defied taboo and skepticism to transform how we protect ourselves from disease and disaster. Guest: Dr. Barry Davis, professor emeritus, University of Texas School of Public Health, author, The Preventioneers Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

On this Make A Difference Minute, I talk with Dr. W. Craig Noblett, President of the American Association of Endodontists, about the connection between oral health and overall health. Dental problems aren't always just about teeth. Infections and untreated issues can affect daily life and, in some cases, become serious health concerns. Dr. Noblett shares warning signs people should pay attention to, including sensitivity to hot or cold temperatures, pain while biting, and discomfort that could signal a bigger issue developing. Sometimes taking care of a small problem early can prevent a much bigger one later. This MADM is brought to you by Bankston Motor Homes, proudly supporting stories and the people who make our communities strong. Real stories. Real people. Real impact. News That Unites!™️

The ESCMID Global Late Breakers series returns to Communicable! Five CMI Communications editors – Marc Bonten, Josh Davis, Angela Huttner, Anne-Grete Märtson, and Erin McCreary – handpicked five late-breaking trials presented at ESCMID Global 2026 to summarise their  findings and discuss whether the results will change their practice. This is part one of the two-part series. Trials presented are listed below and links to their respective sessions can be watched and rewatched on the ESCMID Global Virtual Platform. Links to corresponding publications, if available, and mentioned related articles are provided as well. The FAST trial (Late-breaking research from JAMA)Banerjee R, et al. Fast Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia. The FAST Randomized Clinical Trial, doi: 10.1001/jama.2026.5487 Srinivasan A. A Multinational Trial of Rapid Antimicrobial Susceptibility Testing. Is FASTer Better?, doi: 10.1001/jama.2026.5504The CEFMEC trial (Poster session)Hayakawa K, et al. Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli, Antimicrob Agents Chemother 2023, doi: 10.1128/aac.00510-23The COBRA trial (Late-breaking trials in surgical infection prevention)Overdevest AG, et al. Antibiotic treatment for 1 day versus 4-7 days in patients with acute cholangitis after adequate endoscopic biliary drainage (COBRA): study protocol for a randomized controlled trial. Trials, doi: 10.1186/s13063-026-09524-7The DOTS trial, a secondary analysis (Late-breaking research from JAMA)Lodise, TP, et al. Pharmacokinetics of Dalbavancin in Complicated Staphylococcus aureus Bacteremia: A Secondary Analysis of the DOTS Randomized Clinical Trial, JAMA 2026, doi: 10.1001/jamanetworkopen.2026.11652 Walls G, et al. Patient-reported Perceptions, Experiences, and Preferences Around Intravenous and Oral Antibiotics for the Treatment of Staphylococcus aureus Bacteremia: A Descriptive Qualitative Study, Clin Infect Dis 2026, doi: 10.1093/cid/ciaf522Turner  NA , et al.  Dalbavancin for treatment of Staphylococcus aureus bacteremia: the DOTS randomized clinical trial. JAMA 2025, doi: 10.1001/jama.2025.12543 Maribavir for clinically significant cytomegalovirus infection in hematopoietic cell transplantation: a real-world retrospective international study of the Infectious Disease Working Party of EBMT (Late-breaking research from The Lancet)Paviglianiti A, et al. Maribavir for clinically significant cytomegalovirus infection in haematopoietic cell transplant recipients in Europe: a real-world multicentre retrospective registry study. Lancet 2026. doi: 10.1016/S1473-3099(26)00144-1

Fighting The Status Quo: The Rebels Who Changed Public Health Forever Prevention is built into so many aspects of our lives, from coffee cup lids to seatbelts. However, many of these life-saving innovations were historically met with extreme public and professional resistance. Our expert explores "preventioneers" – the people who defied taboo and skepticism to transform how we protect ourselves from disease and disaster. Guest: Dr. Barry Davis, professor emeritus, University of Texas School of Public Health, author, The Preventioneers Host: Greg Johnson Producer: Kristen Farrah  Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Plus: The Prime Minister speaks alongside the Premier of Alberta, Donald Trump returns to the U.S., the price of gas is rising, Drake drops three new albums, and smart glasses: the good, the bad, and the unregulated. We love feedback at The Big Story, as well as suggestions for future episodes. You can find us: Through email at hello@thebigstorypodcast.ca  Or @thebigstory.bsky.social on Bluesky

Listen in to learn the latest on ART switch strategies for people living with virologically suppressed HIV. Hear from experts Chloe Orkin, MBChB, FRCP, MD, and Peter J. Ruane, MD, as they review how the recent approvals fit in the treatment landscape of 2-drug, single-tablet regimens. Stream on the go or follow along with our expert-curated slides.  Topics covered include:  Guideline recommendations on ART switch in the setting of virologic suppression Phase III clinical trial data supporting ART switch Individual considerations for ART switch Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. Presenters: Chloe Orkin, MBChB, FRCP, MD Professor of Infection and Inequities Dean for Healthcare Transformation Faculty of Medicine and Dentistry Queen Mary University of London London, United Kingdom of Great Britain and Northern Ireland Honorary Consultant Physician Barts Health NHS Trust London, United Kingdom Peter J. Ruane, MD President Ruane Clinical Research Los Angeles, California Link to program page: https://bit.ly/3PkPoP4 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Plus: Honda suspends plans for a new Canadian plant, Trump's Beijing visit, the country's springtime real estate market showed signs of slowing sales, and who will headline the first-ever World Cup Final halftime show. We love feedback at The Big Story, as well as suggestions for future episodes. You can find us: Through email at hello@thebigstorypodcast.ca  Or @thebigstory.bsky.social on Bluesky

Advances in immunotherapies for multiple sclerosis and related disorders have increased the risk of infections and raised important questions about vaccination efficacy. This episode reviews infection risks across treatment classes, emphasizes the importance of monitoring and patient education, and discusses optimal vaccine timing to preserve protective immune responses. In this episode, Aaron L. Berkowitz, MD, PhD, FAAN, speaks with Avindra Nath, MBBS, FAAN, coauthor of the article "Infection Risk and Vaccine Considerations in Multiple Sclerosis and Related Disorders" in the Continuum® April 2026 Multiple Sclerosis and Related Disorders issue. Dr. Berkowitz is a Continuum® Audio interviewer and a professor of neurology in the Department of Neurology at the University of California, San Francisco, in San Francisco, California. Dr. Nath is the chief of the Section of Infections of the Nervous System at the National Institute of Neurological Disorders and Stroke, National Institutes of Health, in Bethesda, Maryland Additional Resources Read the article: Infection Risk and Vaccine Considerations in Multiple Sclerosis and Related Disorders Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @AaronLBerkowitz Full episode transcript available here Dr Berkowitz: Over the last decades, there has been a revolution in the treatment of multiple sclerosis, neuromyelitis optica spectrum disorder, and other immune-mediated neurologic conditions with countless new, highly effective medications. However, with every new treatment comes new risks; and in the case of immunomodulatory therapy, many of those risks relate to infection. Today, I have the privilege of talking with an expert on this topic, Dr Avindra Nath, about the infectious risks of treatments for multiple sclerosis and other immune-mediated neurologic disorders.  Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast.  Dr Berkowitz: This is Dr Aaron Berkowitz, and today I'm interviewing Dr Avi Nath about his article on vaccine considerations and infection risk in multiple sclerosis and related disorders, which he coauthored with Dr Amit Bar-Or. This article appears in the April 2026 Continuum issue on multiple sclerosis. Welcome to the podcast, Dr Nath, and could you please introduce yourself to our audience?  Dr Nath: Thanks very much for inviting me to this podcast. I'm absolutely delighted to have the opportunity to discuss our areas of interest and expertise related to infections and vaccinations for MS patients. My area has been studying the infections of the nervous system since the beginning of the AIDS pandemic, and over the years and decades, we've developed expertise related to various types of CNS infections. That includes ones that are developing in individuals who have immune compromise due to a variety of different reasons. Dr Berkowitz: Fantastic. Well, glad to have the opportunity to speak with you today. When I was in medical school---and you were my attending, actually, we were just reminiscing, which we probably think was not that long ago, but is now over twenty years ago---there were just two medications for MS, right? Beta interferon and glatiramer acetate. And now we have over a dozen, and it's amazing to think of all the progress in these last two decades, as well as for related diseases like NMO. I don't think we even had the aquaporin-four biomarker, right, when I was working with you as a med student in the early 2000s. Dr Nath: And that certainly dates me a lot.  Dr Berkowitz: Both of us.  Dr Nath: Yeah.  Dr Berkowitz: Of course, with all these new treatments, these have been amazing advances for our patients, right? But these come with new treatment-related risks to monitor for with the immunomodulatory medications for MS and related disorders. And one of those most important risks is that of infection. So, your article reviews the potential infectious complications of medications used to treat MS, NMO, etc, and also covers considerations related to thinking about vaccines in this patient population. So, as the MS treatment landscape grows, I can say as a general neurologist, keeping up with all these medications and what to screen for and what to worry about and when to vaccinate just becomes more challenging every year. And your article has so many helpful tables, some organized by medicine, some organized by- sorry, medication, some organized by infection, some by vaccines. So, this is gonna be a great resource for our providers to print out and tape up in their clinic rooms. We won't be able to get into all the depth and detail that you have in this article today, but I do want to focus on some of the key points here related to the common medications we use for MS and which infections to think about and which vaccine considerations we might need to keep in mind for these medications. But before we delve into the drugs, I just wanna ask you more broadly, you talk in the article about the challenge of patients with immune-mediated diseases who are on immunomodulatory therapy being at risk for both flares of their disease and for infections; and these infections can present somewhat atypically, right, in immunomodulated hosts, to maybe coin a term you can correct me on, because they can't mount the full inflammatory response. So how do you approach new symptoms in patients on these immunomodulatory medicines as far as distinguishing disease flare from a treatment-related infection?  Dr Nath: So, I have to say that although a lot of new treatments have come along for MS, and they've really, you know, improved the outcome tremendously and there are so many different options, it has also kept people like me relevant because they cause a lot of various types of infections, and so keeps me in business all the same. But just as you mentioned, there's so many of them, even I have difficulty keeping track of what does what. So, you do need to be able to refer back to published literature, and the tables, I hope, will be quite useful in that regard. You're absolutely right, and you can get new infections, you can get reactivation of existing infections, and you can get atypical presentations of various types of infections that you may not normally think of. So that presents multiple challenges to the treating physician. The other interesting thing about MS is, just as you mentioned, that you already have CNS lesions to begin with. Now, on top of it, you have an infection, so now how to sort out what is the existing disease and what is the infection, it can again become challenging. But one thing is for sure: all these infections are caused by an organism. So, what you really need to do is, the underlying diagnostic is to demonstrate the presence of the organism. Whether you demonstrate it depending on the infection in the spinal fluid or in the brain or, you know, some peripheral organ system, that is going to be key to making the diagnosis. So, all your clinical acumen is good, but that alone may not be sufficient. Dr Berkowitz: Very good. So, when you see a, a patient now who has a new neurologic symptom in the context of an immune-mediated disease who's on immunomodulatory therapy, what goes through your mind? Are you thinking this disease and this drug, and sort of what are the infections, and does the syndrome match? Or are you thinking, you know, you can't always rely on the imaging to distinguish between, say, a flare of an MS and PML because white matter lesions could look similar? How do you sort of approach this scenario when it comes up?  Dr Nath: So, you're right. You have to keep an open mind so that even though you know some infections are more likely to occur with certain types of medications, that doesn't mean that others cannot occur. So, I think when you first see the patient, you should not jump to conclusions, but rather have an open mind. But yes, for example, your patient is on natalizumab, the chances of PML are going to be high. It's a very interesting drug. It does not cause immune compromise in the periphery, but what it's doing is preventing these cells from getting into the brain. So, because then it's acting at the blood-brain barrier. So that means that organisms that are already present in the brain have an opportunity to get reactivated. Turns out you don't have a lot of organisms in the brain, except JC virus seems to be one of them that does somehow, in some individuals, manage to reside out there. And so that can get reactivated. It can get reactivated in the periphery and then enter the brain, too. So, where the very specific mutations have to occur in that virus in order to take residence in the brain. That would be a suspicion that you might have, and MRI can be useful in, again, helping you think about that possibility. If you have typical lesions involving the U fibers, they're demyelinating, usually you do not have much edema around them because patient is immune compromised, but certainly within the brain in these individuals. And so, then you need to demonstrate the organism. The demonstration of the organism should be in the spinal fluid and not in the blood because in the virus, it can-- is reservoir in the kidneys and in the lymph nodes, and periodically it'll shed into the blood. Detection of the organism in the blood can be a false positive, but in the spinal fluid, it shouldn't be there unless you have an infection. Or if you cause a traumatic tap, I guess, if a patient is viremic, that's a possibility, but those are extremely rare. So at least for PML, that's the way that you would diagnose it. Now, you can develop, for example, if an individual is on fingolimod, you can get a wide variety of infections. Here it's a totally different type of mechanism of action. Here the cells are trapped within the lymph nodes, so that means now your entire periphery is immune compromised, right?  So here you can get viral infections, bacterial infections, fungal infections. So here, if a patient presents with new neurological symptoms, you have to have a really open mind for all these possibilities. Now, let's say a patient was on dimethyl fumarate, and dimethyl fumarate causes neutropenia early on. So here you have to worry about an individual developing bacterial infections, so latent tuberculosis or bacterial meningitis can occur in these individuals. That's something to keep in mind. It's not that other infections cannot occur with dimethyl fumarate, you can see PML and other things too, but the chances of bacterial infections are greater. So, you got to make sure that you draw all the cultures for that purpose. Similarly, if you're on a complement inhibitor, like a C5 inhibitor or the thing that I could use in NMO, there are the chances of meningococcal meningitis. So, these patients, you need to prevaccinate them before you start these kinds of treatments and look for that possibility. When you suspect bacterial infections, particularly acute bacterial meningitis, there time is of essence. Also, in some of the acute viral infections, for example---herpes encephalitis is another one---you have to be so careful, and if you suspect any of them, even if they're with possibly atypical manifestations, you treat first and then diagnose later, and draw all your cultures, whatever you need to, and just treat them. And these infections can also cause cerebral edema, so one has to be careful about doing spinal taps in these individuals. You want some kind of neuroimaging before you do them. In the days when we didn't have neuroimaging, we used to say, "Okay, if your patient has focal neurological signs or is comatose, you don't do it." But these days, you can get imaging very quickly and very easily. All the-- Because of our stroke management, we've learned how to do them so quickly. So, I think there's little excuse not to do imaging and prevent herniation from occurring.  Dr Berkowitz: That's very helpful. So, using the information we know about the drug, and we're going to rapid-fire review some of that in a bit to know what infections the patient is susceptible to, but acknowledging that any patient can get any infection, right? Whether they're on particular medications or not. And then if you're not sure, based on the neuroimaging, which as you said, is helpful, but not always helpful in distinguishing between infections and flares or, as you said, in the case of meningitis, encephalitis, early on at least, especially in immunocompromised or immunomodulated, quote unquote, patient might not see the typical imaging. So really, when safe, getting CSF or cultures, PCRs, and other infectious studies too is really gonna be the definitive diagnostic maneuver here. Is that fair summary across the board?  Dr Nath: I think you said that absolutely right. And you summarized that correctly. And, you know, thing about infection, a lot of neurological diseases are, you know, diagnosed by clinical acumen, like your Parkinson's and Alzheimer's and others. Think about infections is caused by an organism, demonstrate the organism, right? That should be your goal. It doesn't mean that clinical acumen is not important, but here you have an opportunity to demonstrate the organism, so you should depend upon that.  Dr Berkowitz: Okay. Well, you gave us a nice segue by talking about some of the infections to worry about with some of the medications. So what I'd like to do now for the sort of second half of our interview here is to go through some of the more common medications used for MS, and if we have time, for NMO, and just sort of go kind of rapid fire here, and for each medication, if you can tell us the kind of top infectious concerns and whether when to consider them or what screening needs to take place before or during administration of the medication, and then any vaccine considerations we should be aware of. Some of these will obviously be quite short depending on the medicine. So, going back to the two medications I alluded to earlier that were the only ones in play when you and I last saw each other on the wards when I was a medical student, beta interferon, glatiramer acetate, any infections or vaccine considerations with these medications?  Dr Nath: No, I think they're probably your safest medications now as far as immunomodulatory therapies are concerned. These two, and IVIG, if you ever use them, are probably the safest, do not require any vaccine considerations, per se. Dr Berkowitz: Perfect. Okay. So, moving on to fingolimod and others in the sphingosine-one phosphate receptor modulator family, what are the infectious considerations? Any prescreening or vaccination considerations?  Dr Nath: I think all your patients should be prescreened for antibodies to JC virus, because there is a risk for PML, and those who are positive should be closely monitored. So, it's not an absolute contraindication for using these medications, but they just require closer monitoring. With this class of drugs, PML is of consideration. Also, these varicella-zoster virus infection, yeah, with that you can develop zoster encephalitis or myelitis. It can present with motor symptoms as well, which can be atypical. You don't usually see them otherwise in immune-competent individuals. So, varicella-zoster, sometimes you can develop encephalitis, also vasculitis with varicella-zoster, so one has to be careful. So, getting the shingles vaccine can be actually very helpful to prevent these things. And then some patients can even develop herpes simplex encephalitis also, and that can be extremely atypical. So, they don't- they can involve the basal ganglia, can involve the brain stem and cerebellum. So again, your index of suspicion should be very high. Interestingly, although HSV encephalitis has been associated with NMDA receptor encephalitis, those reports of NMDA receptor encephalitis have not been published yet with NMS patients. Not sure why, maybe they just have been missed. But that doesn't seem to be a major concern. And then there are a whole host of other infections that can occur with this class of drugs, and that can include toxo; fungal infections, particularly crypto. There's a case report of histoplasmosis; hepatitis virus, particularly hepatitis C; and then the poxvirus is a good example. You can get molluscum contagiosum; warts with papillomavirus; you can get atypical mycobacteria; and even Kaposi sarcoma, which is HHV8. So, there's a huge variety of infections with the sphingosine one phosphate receptor modulators.  Dr Berkowitz: And any- aside from screening for JC virus before initiating these, any- and then continuing to monitor for JC antibody index, any other considerations as far as labs to send, monitoring before or on the drug or vaccine considerations for patients on fingolimod and the others in this category, siponimod, etcetera?  Dr Nath: Yeah, there are a lot of things to consider. All the details are really available in the chapter if you look at them. But briefly, all the things that one could potentially vaccinate patients for, all these infections I mentioned, one should do so. The timing is critical so that if you can do it before treatment, I think, before starting treatment, that is absolutely important. And you got to give them at least, you know, two to three weeks for these vaccines to take effect before starting your medication. If your patient already arrives on a medication, then you got to play this game of you know, before the next dose, give them again two to three weeks before the next dose and start vaccinating them and get all the vaccines in. Broadly, about the things to worry about the vaccines are you have live vaccines, and you've got the inactivated vaccines or the subunit vaccines. You have to be careful with live vaccines, because if your patient is immunocompromised, that virus can sometimes itself cause harm. For example, you know, yellow fever is one, and there you can develop encephalitis from it. Measles, mumps, rubella, these are all live vaccines. Now, the good thing is that a lot of us have been immunized very early in childhood, but that may not be the case any longer. And so, these things, one has to be very careful with when you're giving live vaccines, that we want to avoid them as much as possible, and individuals are gonna be immune-compromised. But all the others, meningococcus, for example, you should- the HPV vaccines, the varicella zoster vaccines, all these things, you've got to pre-vaccinate and make sure that they have an antibody response to them before starting immunocompromising therapy. Dr Berkowitz: Perfect. Okay, moving on to some of the other orals. What infectious and/or vaccine considerations do we have with teriflunomide?  Dr Nath: Okay, yeah. Teriflunomide is a very interesting drug. It's relatively safe. There is concern about the possibility of varicella zoster infection, people have reported that, and also tuberculosis. But PML is extremely rare, if not at all, and we haven't seen herpes encephalitis quite yet.  Dr Berkowitz: Got it. How about dimethyl fumarate? Dr Nath: Yeah. So dimethyl fumarate is... as I mentioned earlier, it's interesting because it causes this neutropenia. It's transient, but it occurs early on, and these patients can be at risk of PML, although small. They can develop varicella zoster virus infection, herpes encephalitis, and also fungal infections. For example, cryptococcal infection has been reported with dimethyl fumarate. Dr Berkowitz: Okay. We've spoken a bit about natalizumab and PML, and you have extensive information on this in your article, and I'll defer the reader to that. But for natalizumab, what are the key points every neurologist should know about natalizumab and PML as far as from the practical perspective, screening, frequency of screening, when to worry, when to not use natalizumab at all in the first place based on what you find in your screening for JC virus? What are the key points every neurologist should know?  Dr Nath: Uh, yes. You bring up an important point, and that is all patients should be monitored for JC virus. If they're JC virus-negative, so that's your most ideal patient to go on natalizumab, but that doesn't mean they cannot get infected with the virus. In fact, there's an interesting study claiming that, you know, patients, when they get these infusions, they're all sitting in the same room getting infused. Some have JC virus, some don't have JC virus, and so there's the potential that we may be aiding the transmission here in some way or another. The virus is an interesting one. It comes out in urine, and then it's spread through oral contamination, gets into the tonsils, and then spreads from there to your marrow and resides in the kidney and the marrow, as well as the lymph nodes, forever. So, you, you have to monitor these patients to see that during the course, even if they're negative, they could turn out positive. So, every six months or a year, an antibody test should be done on all patients irrespective. If a patient already has antibodies, that's not an absolute contraindication. It just means you've got to monitor them closely for development of new symptoms, and if, whenever there are new symptoms, don't just assume this is due to MS, but just make sure the MRI is done with and without contrast. The- and if there's still a suspicion, that you do a CSF evaluation for JC virus. Just detecting, looking for JC virus in the blood, a rising titer is another thing that can help you. And so, the titer is also important. And the reason you have rising titers is it means that there's an infection that's already occurred in the brain, and the immune system is reacting to that infection by increasing titers. But that alone is not sufficient to make the diagnosis. You still- that gives you an index of suspicion. You've got to then do the MRI and the spinal tap to, you know, be absolutely certain. So, each patient is a little bit different, so the way you monitor them is going to depend on where they are. You know, if they've had prior immunomodulatory therapy before starting natalizumab, or if they're on natalizumab for more than two years, then the chances of PML are much greater, so you may want to monitor them more closely. Uh, they never had any prior immunomodulatory therapy, you're just starting natalizumab, maybe once a year is sufficient. So, I think you've got to tailor it depending on what your risks are for each patient. Dr Berkowitz: Perfect. That's very helpful. And again, you write extensively about PML and natalizumab and PML considerations in your article. So, for a more detailed and in-depth discussion of what we just discussed, definitely hope readers will take a look at your article. Okay. Last but not least---certainly not least, 'cause we're using these probably, it seems, the most commonly in many places I've worked---rituximab, ocrelizumab are B-cell therapies for MS. What are some of the infectious and vaccine considerations related to these infusion medications?  Dr Nath: So, there's concern for PML with anti-B-cell therapies also, maybe not to the same degree as natalizumab, but the same principles should be applied. A lot of people think that these are relatively safe. I don't think so. I think we see enough number of patients on B-cell therapies with PML. So, I would use the same caution because these infections are... you know, can be fatal. So, one should be very careful, even with anti-B-cell therapies. And just with natalizumab, you also have the risk of VZV infection causing shingles. HSV1 has been reported, but there's another interesting complication that has been reported with anti-B-cell therapies, and that is severe West Nile encephalitis. And as mosquitoes-borne diseases are getting more and more prevalent, and we're seeing West Nile cases erupting every summer, I think one's got to be, you know, very cognizant of the fact that this can occur. These patients should take precautions to prevent mosquito bites from occurring and not expose themselves to areas where they could be at risk for it. Unfortunately, there is no vaccine for it and no specific treatment for West Nile. So, all one can do is use prevention strategies for mosquito bites.  Dr Berkowitz: Yeah, I'm glad you mentioned that. I think the only really truly severe neuroinvasive cases I've seen of West Nile virus have indeed been in patients who were being treated with B-cell therapy. Not, if I'm remembering correctly, for immune-mediated disease, but for a lymphoma, so probably other confounding factors there. But yeah, it's a disease we learn about and think about, but I've only seen the most severe cases in patients who had abnormal immune systems, so I'm glad you flagged that. This has been a very helpful discussion, and I've learned a lot from you. I learned a lot from your article, just as I did when you were my attending some 20-something years ago on the wards when I was a medical student. So, it's good to continue learning from you through your writing and research, and today from getting to talk to you again. I encourage our readers to read your article and to bookmark those tables for when these considerations come up for your patients on these immunomodulatory therapies and you're wondering which infections to worry about and how to manage vaccines in this patient population. So again, today I've been interviewing Dr. Avi Nath about his article on vaccine considerations and infection risk in multiple sclerosis and related disorders, which he wrote with Dr. Amit Bar-Or. This article appears in the April 2026 Continuum issue on multiple sclerosis. Be sure to check out Continuum Audio episodes from this and other issues, and thank you again to our listeners for joining today.  Dr Nath: Thank you so much, Aaron, for that wonderful interview, and I'm extremely proud of all your accomplishments over the last 20 years. You've done an amazing job, and it was such a pleasure to see you and to be able to do this interview with you. Thank you again.  Dr Berkowitz: Thanks. That means a lot. I never would have imagined- we won't say 20, how many, but 20-something years ago as the medical student looking up to you and all your expertise on these infections and all of your research that led to so much of our understanding on these, that I would find myself interviewing you two decades later. So, for all the students listening, you never know where you'll end up, but I appreciate your very kind words.  Dr Nath: That's what we hope for all our students. Thank you so much.  Dr Berkowitz: Thanks again.  Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

It's been an ordeal for those who embarked on a cruise across in early April and it's not over yet. The ship's passengers are being repatriated across the world after potential exposure to hantavirus, which caused the death of three passengers. Among those heading home are four Australians who will soon be placed in a quarantine facility in Western Australia. What is the virus, how does it spread and should we be worried about it?  Today epidemiologist Raina MacIntyre from UNSW on everything you need to know about hantavirus. Featured: Raina MacIntyre, epidemiologist and Professor of Global Biosecurity at the University of New South Wales

Plus: Trump lands in Beijing, King Charles throne speech, the Artemis II crew meets Carney, an American coffee giant is coming to Canada, and integrating Indigenous healthcare could solve Manitoba's HIV crisis. We love feedback at The Big Story, as well as suggestions for future episodes. You can find us: Through email at hello@thebigstorypodcast.ca  Or @thebigstory.bsky.social on Bluesky

Plus: Deadline day for the 2026 census, British PM faces resignation calls, Donald Trump visits Beijing, more sanctions against Russia, and what the Alberta data leak can teach us about separatists. We love feedback at The Big Story, as well as suggestions for future episodes. You can find us: Through email at hello@thebigstorypodcast.ca  Or @thebigstory.bsky.social on Bluesky

Dr. Don and Professor Ben talk about the risks from touching your phone in the middle of prepping dinner. Dr. Don - not risky

Tick season is well underway in many parts of the country. It seems that a mild winter and a warm spring have brought the nymphs out seeking blood. If that blood is yours, you may be exposed to a range of pathogens. What's more, ticks are not the only creatures ready to bite you. Fleas […]

On today's episode, Andy Frisella & DJ discuss Spirit Airlines shutting down and what stranded passengers can do to get home, reports from the World Health Organization on suspected Hantavirus deaths aboard a cruise ship, and a high school student going viral after exposing classmates struggling with basic reading skills.

Join Captain Jeff, Captain Nick, Alpha Juliet, and Producer/Curator Liz. Enjoy! APG 706 SHOW NOTES WITH LINKS AND PICS 00:00:00 Introduction 00:06:22 FEEDBACK 00:06:46 Brian from Katy, Texas – LaGuardia Plane Crash 00:11:21 Andy Harris – Retirements 00:24:48 Deanna Tickle – It’s Me Again! 00:33:22 Murilo Barbosa – Landing on the Wrong Airport 00:43:42 Steve Simpson – APG701 FedEx/Alaska Close Call 00:46:55 Mahzuz Karim – Go Arounds 00:58:50 GETTING TO KNOW US 01:21:51 NEWS 01:22:09 Firefighters Likely Had Limited View of Approaching Plane in LaGuardia Crash 01:32:51 Port Authority to Install Tracker Not Used During Deadly LaGuardia Crash 01:43:23 FINAL REPORT – Hop-A-Jet – Challenger Crash 01:56:42 WRAP UP Watch the video of our live stream recording! Go to our YouTube channel! Give us your review in iTunes! I’m “airlinepilotguy” on Facebook, and “airlinepilotguy” on Twitter. feedback@airlinepilotguy.com airlinepilotguy.com ATC audio from https://LiveATC.net Intro/outro Music, Coffee Fund theme music by Geoff Smith thegeoffsmith.com Dr. Steph’s intro music by Nevil Bounds Capt Nick’s intro music by Kevin from Norway (aka Kevski) Copyright © AirlinePilotGuy 2026, All Rights Reserved Airline Pilot Guy Show by Jeff Nielsen is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License

Part one of this quarter's edition of Unearthed! includes animals, artwork, edibles and potables, shipwrecks, potpourri. Research: Abdallah, Hannah. “Analysis of charred food in pot reveals that prehistoric Europeans had surprisingly complex cuisines.” EurekAlert. 3/4/2025. https://www.eurekalert.org/news-releases/1117763 Almeroth-Williams, Thomas. “British redcoat’s lost memoir reveals harsh realities of life as a disabled veteran.” EurekAlert. 1/14/2026. https://www.eurekalert.org/news-releases/1111595 Anderson, Sonja. “Does This Skeleton Found Beneath a Dutch Church Belong to D’Artagnan, the Man Who Inspired ‘The Three Musketeers’?” Smithsonian. 3/27/2026. https://www.smithsonianmag.com/smart-news/this-skeleton-found-beneath-the-floor-of-a-dutch-church-may-belong-to-dartagnan-the-fourth-musketeer-180988448/ Anderson, Sonja. “Historians Thought This Rare Renaissance Portrait by One of the First Famous Female Artists Was Lost to History—Until It Surfaced in North Carolina.” 2/3/2026. https://www.smithsonianmag.com/smart-news/historians-thought-this-rare-renaissance-portrait-by-one-of-the-first-famous-female-artists-was-lost-to-history-until-it-surfaced-in-north-carolina-180988120/ Anderson, Sonja. “Hundreds of Ancient Roman Blade Sharpeners Emerge From a Riverbank in England, Revealing the Ruins of a 2,000-Year-Old Whetstone Factory.” Smithsonian. 1/20/2026. https://www.smithsonianmag.com/smart-news/hundreds-of-ancient-roman-blade-sharpeners-emerge-from-a-riverbank-in-england-revealing-the-ruins-of-a-2000-year-old-whetstone-factory-180988016/ Anderson, Sonja. “The Italian Government Just Paid Nearly $35 Million for a Rare Caravaggio Portrait—One of the Most Expensive Artworks It’s Ever Acquired.” Smithsonian. 3/16/2026. https://www.smithsonianmag.com/smart-news/the-italian-government-just-paid-nearly-35-million-for-a-rare-Caravaggio-portrait-one-of-the-most-expensive-artworks-its-ever-acquired-180988344/ Arnold, Paul. “Poop as medicine? A Roman vial's chemistry backs up ancient medical texts.” Phys.org. 2/4/2026. https://phys.org/news/2026-02-poop-medicine-roman-vial-chemistry.html Arnold, Paul. “Scents of the afterlife: Identifying embalming recipes by 'sniffing' the air around Egyptian mummies.” Phys.org. 2/5/2026. https://phys.org/news/2026-02-scents-afterlife-embalming-recipes-sniffing.html#google_vignette Bacon, Jordan. “English history’s biggest march is a myth – King Harold sailed to the Battle of Hastings.” EurekAlert. 3/20/2026. https://www.eurekalert.org/news-releases/1120082 Bastola, Kunjal. “A Groundskeeper Noticed a Sinkhole on a Golf Course. It Turned Out to Be a Wine Cellar Full of Empty Bottles, Untouched for More Than 100 Years.” Smithsonian. 3/19/2026. https://www.smithsonianmag.com/smart-news/a-groundskeeper-noticed-a-sinkhole-on-a-golf-course-it-turned-out-to-be-a-wine-cellar-full-of-empty-bottles-untouched-for-more-than-100-years-180988379/ Bastola, Kunjal. “A Little Boy’s Library Book Was Due in 1989. Thirty-Six Years Later, He Realized His Parents Had Never Returned It.” Smithsonian. 1/26/2026. https://www.smithsonianmag.com/smart-news/a-little-boys-library-book-was-due-in-1989-thirty-six-years-later-he-realized-his-parents-had-never-returned-it-180988046/ Baum, Stephanie. “Ancient parrot DNA reveals sophisticated, long-distance animal trade network pre-dating the Inca Empire.” 3/10/2026. https://phys.org/news/2026-03-ancient-parrot-dna-reveals-sophisticated.html Baum, Stephanie. “From the Late Bronze Age to today, the Old Irish Goat carries 3,000 years of Irish history.” 2/26/2026. https://phys.org/news/2026-02-late-bronze-age-today-irish.html Benzine, Vittoria. “What Did Pompeii Smell Like? A New Study Analyzes Its Ancient Incense.” Artnet. 3/31/2026. https://news.artnet.com/art-world/pompeii-ritual-incense-study-2760240 Brooks, James. “Danish warship sunk by Nelson’s British fleet discovered after 225 years.” Associated Press. 4/2/2026. https://apnews.com/article/denmark-archaeologists-warship-nelson-copenhagen-dannebroge-lynetteholm-4519533d9e774a490f6020e893634e09 Carvajal, Guillermo. “Archaeologists achieve a historic milestone by dating French cave paintings with carbon-14 for the first time.” 3/10/2025. https://www.labrujulaverde.com/en/2026/03/archaeologists-achieve-a-historic-milestone-by-dating-french-cave-paintings-with-carbon-14-for-the-first-time/ Clayworth, Liv. “Bird poop powered the rise of the Chincha Kingdom, archaeologists find.” EurekAlert. 2/11/2026. https://www.eurekalert.org/news-releases/1115214 “Lost page of the Archimedes Palimpsest identified in Blois, central France.” Phys.org. 3/9/2026. https://phys.org/news/2026-03-lost-page-archimedes-palimpsest-blois.html Ehrlich, Claudia. “Signs on Stone Age objects: Precursor to written language dates back 40,000 years.” EurekAlert. 2/23/2026. https://www.eurekalert.org/news-releases/1117179 Ferrer, Isabel. “Is d’Artagnan lying beneath a church in Maastricht? DNA will determine if remains found are those of the famous musketeer.” El Pais. 3/25/2025. https://english.elpais.com/international/2026-03-25/is-dartagnan-lying-beneath-a-church-in-maastricht-dna-will-determine-if-remains-found-are-that-of-the-famous-musketeer.html?outputType=amp Gebauer, Kathryn. “Groundbreaking discovery reveals Africa’s oldest cremation pyre and complex ritual practices.” EurekAlert. 1/1/2016. https://www.eurekalert.org/news-releases/1111191 Harley, Sadie. “Iron Age dental plaque reveals Scythians consumed milk from horses and ruminants.” Phys.org. 1/21/2026. https://phys.org/news/2026-01-iron-age-dental-plaque-reveals.html He, Ye. “Singapore’s first ancient shipwreck reveals record cargo of Yuan dynasty blue-and-white porcelain.” EurekAlert. 2/12/2026. https://www.eurekalert.org/news-releases/1116512 Johansen, Rikke Tørnsø. “Archaeologists reveal a medieval super ship: "It's the World’s largest cog".” Vikingeskibs Museet. 12/22/2025. https://www.vikingeskibsmuseet.dk/en/news/archaeologists-reveal-a-medieval-super-ship-its-the-worlds-largest-cog Kasal, Krystal. “Hannibal's famous war elephants: Single bone in Spain offers first direct evidence.” Phys.org. 2/5/2026. https://phys.org/news/2026-02-hannibal-famous-war-elephants-bone.html Kasal, Krystal. “Oldest known sewn hide and other artifacts from Oregon caves shed light on early clothing in harsh climates.” Phys.org. 2/10/2026. https://phys.org/news/2026-02-oldest-sewn-artifacts-oregon-caves.html Killgrove, Kristina. “Romans used human feces as medicine 1,900 years ago — and used thyme to mask the smell.” 1/29/2026. https://www.livescience.com/archaeology/romans/romans-used-human-feces-as-medicine-1-900-years-ago-and-used-thyme-to-mask-the-smell Killgrove, Kristina. “Stone Age woman was buried like a man, revealing flexible gender roles 7,000 years ago in Hungary.” LiveScience. 3/3/2026. https://www.livescience.com/archaeology/stone-age-woman-was-buried-like-a-man-revealing-flexible-gender-roles-7-000-years-ago-in-hungary Koc University. “Earliest evidence of indigo-dyed textiles and single-needle knitting discovered in Bronze Age Anatolia.” Phys.org. 2/21/2026. https://phys.org/news/2026-02-earliest-evidence-indigo-dyed-textiles.html Kuta, Sarah. “Did Neanderthals Use Birch Bark Tar as an Antibiotic to Treat Wounds and Infections?” Smithsonian. 3/30/2026. https://www.smithsonianmag.com/smart-news/did-neanderthals-use-birch-bark-tar-as-an-antibiotic-to-treat-wounds-and-infections-180988393/ Kuta, Sarah. “Ostrich Eggshells Suggest Our Ancestors May Have Understood Basic Geometry 60,000 Years Ago.” Smithsonian. 3/9/2026. https://www.smithsonianmag.com/smart-news/these-intricately-decorated-ostrich-eggshells-suggest-our-ancestors-may-have-understood-basic-geometry-60000-years-ago-180988315/ Kuta, Sarah. “Ötzi the Iceman May Have Carried a Cancer-Causing Strain of HPV, a Common Virus Still Plaguing Humans Today.” Smithsonian. 1/20/2026. https://www.smithsonianmag.com/smart-news/otzi-the-iceman-may-have-carried-a-cancer-causing-strain-of-hpv-a-common-virus-still-plaguing-humans-today-180988024/ Kuta, Sarah. “Shipwreck Timbers Appeared on a Beach After a Storm. They Had Been Buried Beneath the Sand Since the 17th Century.” Smithsonian. 3/2/2026. https://www.smithsonianmag.com/smart-news/shipwreck-timbers-appeared-on-a-beach-after-a-storm-they-had-been-buried-beneath-the-sand-since-the-17th-century-180988260/ Lawson-Tancred, Jo. “Salvador Dalí’s Largest Work Snapped Up by Florida Museum.” Artnet. 3/27/2026. https://news.artnet.com/market/salvador-dali-largest-work-bonhams-sale-2749246 Lock, Lisa. “Ancient DNA finds 15,800-year-old dogs in Anatolia, buried like humans.” Phys.org. 3/28/2026. https://phys.org/news/2026-03-ancient-dna-year-dogs-anatolia.html Lock, Lisa. “Are one in 200 men really related to Genghis Khan? Maybe not, according to a new study.” Phys.org. 2/21/2026. https://phys.org/news/2026-02-men-genghis-khan.html Lucibella, Michael. “Prehistoric tool made from elephant bone is the oldest discovered in Europe.” EurekAlert. 1/26/2026. https://www.eurekalert.org/news-releases/1113140 Luscombe, Richard. “Mass grave in Jordan sheds new light on world’s earliest recorded pandemic.” The Guardian. 1/31/2026. https://www.theguardian.com/science/2026/jan/31/plague-of-justinian-pandemic net. “Did King Harold Sail to Hastings? New Study Sparks Debate Among Historians.” 3/2026. https://www.medievalists.net/2026/03/did-king-harold-sail-to-hastings-new-study-sparks-debate-among-historians/ net. “Viking-Age Woman Buried with Her Dog in Norway.” 3/2026. https://www.medievalists.net/2026/03/viking-age-woman-buried-with-her-dog-in-norway/ Newcastle University Press Office. “5,300-year-old ‘bow drill’ rewrites story of ancient Egyptian tools.” 2/9/2026. https://www.ncl.ac.uk/press/articles/latest/2026/02/ancientegyptiandrillbit/ Noraz, R., Chauvey, L., Wagner, S. et al. Ancient DNA reveals 4000 years of grapevine diversity, viticulture and clonal propagation in France. Nat Commun 17, 2494 (2026). https://doi.org/10.1038/s41467-026-70166-z Nordin, Gunilla. “World’s oldest arrow poison – 60,000-year-old traces reveal early advanced hunting techniques.” 1/7/2026. https://www.eurekalert.org/news-releases/1111624 Parco Archaeologico de Ercolano. “Archaeology: New precious decorations discovered at Villa Sora in the Herculaneum Park.” 2/5/2026. https://ercolano.cultura.gov.it/archaeology-new-precious-decorations-discovered-at-villa-sora-in-the-herculaneum-park/?lang=en Paul, Andrew. “Hiker finds 3,000-year-old bull sculpture in Spain.” Popular Science. 3/17/2026. https://www.popsci.com/science/hiker-finds-bronze-age-bull-spain/ Potter, Lisa. “A wild potato that changed the story of agriculture in the American Southwest.” EurekAlert. 1/21/2026. https://www.eurekalert.org/news-releases/1113056 “Digital scans unveil new love notes and sketches on ancient Pompeii wall.” 1/19/2026. https://www.reuters.com/science/digital-scans-unveil-new-love-notes-sketches-ancient-pompeii-wall-2026-01-19/ Richard L. Rosencrance et al. ,Complex perishable technologies from the North American Great Basin reveal specialized Late Pleistocene adaptations. Sci. Adv. 12, eaec2916(2026).DOI:10.1126/sciadv.aec2916 Ruse, Amy. “Tasmanian tiger lives on in Arnhem Land rock art.” EurekAlert. 3/30/2026. https://www.eurekalert.org/news-releases/1121955 Ruse, Amy. “World’s oldest rock art holds clues to early human migration to Australia.” EurekAlert. 1/21/2026. https://www.eurekalert.org/news-releases/1112900 Siehoff, Jonas. “Hygienic conditions in Pompeii's early baths were poor.” 1/12/2026. https://www.eurekalert.org/news-releases/1112403 Taçon, P. S. C., A.Jalandoni, S. K.May, J.Nganjmirra, and C.Mungulda. 2026. “The Devil Is in the Detail: Tasmanian Devil and Tasmanian Tiger Paintings From Awunbarna and Injalak Hill, Northern Territory, Australia.” Archaeology in Oceania. https://doi.org/10.1002/arco.70024 The History Blog. “$40 estate sale find by early African-American silversmith sells for $24,000.” 2/4/2026. https://www.thehistoryblog.com/archives/75294 The History Blog. “43,000 ostraca found at one site shed light on social history of Egypt.” 5/15/2026. https://www.thehistoryblog.com/archives/75609 The History Blog. “British Museum acquires Tudor Heart.” 2/10/2026. https://www.thehistoryblog.com/archives/75343 The History Blog. “Exceptional Roman cargo shipwreck found in Lake Neuchâtel.” 3/29/2026. https://www.thehistoryblog.com/archives/75705 The History Blog. “Extraordinary find: 10th c. bronze wheel cross matches mold found 43 years ago.” 1/24/2026. https://www.thehistoryblog.com/archives/75220 The History Blog. “Previously unknown Hans Baldung Grien portrait emerges after 500 years in the sitter’s family.” 1/17/2026. https://www.thehistoryblog.com/archives/75161 The History Blog. “Roman wooden writing tablets from Belgium deciphered.” 1/22/2206. https://www.thehistoryblog.com/archives/75207 Thomas, Laura. “A century-old Stonehenge mystery may finally be solved.” Science Daily. 1/27/2026. https://www.sciencedaily.com/releases/2026/01/260127010208.htm Thorsberg, Christian. “The National Gallery of Art Acquires 17th-Century Masterpiece by Baroque Painter Artemisia Gentileschi.” Smithsonian. 2/7/2026. https://www.smithsonianmag.com/smart-news/the-national-gallery-of-art-acquired-17th-century-masterpiece-by-baroque-painter-artemisia-gentileschi-180988147/ Thorsberg, Christian. “This Luxury Steamer Disappeared on a Stormy Night in 1872. Nearly 150 Years Later to the Day, It Was Found at the Bottom of Lake Michigan.” Smithsonian. 2/18/2026. https://www.smithsonianmag.com/smart-news/this-luxury-steamer-disappeared-on-a-stormy-night-in-1872-nearly-150-years-to-the-day-it-was-found-in-the-bottom-of-lake-michigan-180988204/ Unibo Magazine. “Humanity’s oldest geometries, engraved on ostrich eggs.” https://magazine.unibo.it/en/articles/humanitys-oldest-geometries-engraved-on-ostrich-eggs University of Tübingen. “Earliest hand-held wooden tools found in Greece date back 430,000 years.” Phys.org. 1/1/2026. https://phys.org/news/2026-01-earliest-held-wooden-tools-greece.html Villotte, S., T.Szeniczey, S.Kacki, and A.Anders. 2026. “Fixed and Fluid: The Two Faces of Gender Roles—A Combined Study of Activity Patterns and Burial Practices in the European Neolithic.” American Journal of Biological Anthropology189, no. 2: e70217. https://doi.org/10.1002/ajpa.70217. Whiddington, Richard. “3,300-Year-Old Papyrus Reveals How Ancient Egyptians Fixed Drawing Mistakes.” ArtNet. 3/9/2026. https://news.artnet.com/art-world/ancient-egyptian-papyrus-white-out-fluid-2752125 Whiddington, Richard. “Long-Lost Archimedes Text Resurfaces in French Museum.” Artnet. 3/11/2026. https://news.artnet.com/art-world/lost-page-of-archimedes-palimpsest-found-2753005 Whiddington, Richard. “Lost Parthenon Piece Unearthed From Lord Elgin’s Shipwreck.” ArtNet. 3/19/2026. https://news.artnet.com/art-world/parthenon-fragment-lord-elgin-shipwreck-2755894 Zeilsgtra, Andrew. “Breathing in the past: How museums can use biomolecular archaeology to bring ancient scents to life.” EurekAlert. 2/5/2026. https://www.eurekalert.org/news-releases/1114918 Zinin, Andrew. “600-year-old pinot noir grape found in medieval French toilet.” Phys.org. 3/24/2026. https://phys.org/news/2026-03-year-pinot-noir-grape-medieval.html#google_vignette See omnystudio.com/listener for privacy information.